ArticleCancers2019

Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients.

Valentina Marchica et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.